Search
Search Results
##search.searchResults.foundPlural##
-
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2579PDF: 746HTML: 2298 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2221PDF: 1046HTML: 1984Characteristic of study group: 199 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2132PDF: 1696HTML: 378 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2453PDF: 785HTML: 1736 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
2964PDF: 896HTML: 1953 -
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
1530PDF: 539HTML: 272 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2208PDF: 1495HTML: 267 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3925Suppl. Files: 1119PDF: 1069Html: 177 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2206PDF: 947HTML: 5064Cover Letter: 169Figure 2: 161Figure 1: 174Figure 3: 195Figure 4: 166Figure Legend: 186Table 1: 189Table 2: 181Table 3: 181 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3255PDF: 935HTML: 2956 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2842PDF: 848HTML: 6519Untitled: 227Untitled: 189Untitled: 205Untitled: 214 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7446PDF: 2422HTML: 1733Table 1.: 208Table 2.: 217Table 3.: 202Table 4.: 200 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3774PDF: 1662HTML: 11596Figures Haase: 199 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3589PDF: 886HTML: 6711 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1045PDF: 1159Suppl. Files: 569HTML: 88 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1184PDF: 754HTML: 1348Figure 1: 186Figure 2: 189 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2018PDF: 760HTML: 3113 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3892PDF: 1478HTML: 8513 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4311PDF: 1373HTML: 2041 -
TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY
3558PDF: 1067HTML: 875 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1784PDF: 969HTML: 144 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3559PDF: 1578HTML: 80 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1346PDF: 830HTML: 135 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1810PDF: 809HTML: 10235Figures 1,2,3: 175 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
1964PDF: 713HTML: 684Table1: patient's characteristics: 156Table 2: profile of each patient: 178







